AstraZeneca pauses COVID-19 vaccine trial after volunteer falls ill
AstraZeneca on Tuesday announced it has temporarily suspended global trials of a possible COVID-19 vaccine after one of the volunteers experienced a "potentially unexplained illness."
The pharmaceutical company is testing Oxford University's vaccine in the U.S., United Kingdom, Brazil, and South Africa. It is one of three potential coronavirus vaccines now in final Phase 3 trials in the U.S.
It is standard procedure for experimental vaccine trials to pause in order to determine if the vaccine is causing serious reactions in volunteers. AstraZeneca said in a statement that during large trials, "illnesses will happen by chance but must be independently reviewed to check this carefully. We are working to expedite the review of the single event to minimize any potential impact on the trial time lines. We are committed to the safety of our participants and the highest standards of conduct in our trials."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Earlier in the day, AstraZeneca and eight other companies, including Johnson & Johnson and Moderna, signed a pledge promising not to push for early government approval of any coronavirus vaccine.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
The World War Two experiments that made D-Day possible
Under The Radar Scientists performed gruelling tests on themselves paving the way for the iconic invasion
By Chas Newkey-Burden, The Week UK Published
-
Is the Supreme Court about to criminalize homelessness?
Talking Points The court will decide if bans on outdoor camping are 'cruel and unusual'
By Joel Mathis, The Week US Published
-
Fall into the groove at these delightful record stores
The Week Recommends Each one strikes its own chord
By Catherine Garcia, The Week US Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published
-
Visa and Mastercard agree to lower swipe fees
Speed Read The companies will cap the fees they charge businesses when customers use their credit cards
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published
-
Feds cap credit card late fees at $8
speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
By Peter Weber, The Week US Published